FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump’s Greenland obsession isn’t random. Here’s what’s at stake

Trump reaffirms ICE arrest policy after confusing guidance sparks alarm among agents

Disturbing Video: ‘One of the Most Horrific Things I’ve Seen’ – Journalists Disgusted as Illegal Nearly Drowns Toddler in Effort to Cross Border

China Isn’t Waiting for Permits: US Leaders Warn It’s ‘Quicker to Get a College Degree’ Than to Power America

Nonimmigrant visas in flux due to Trump administration fees

The folksy Senate Republican in hot demand on the campaign trail

SCOTUS detention fight could unleash dangerous criminal migrants onto US streets, experts warns

Michigan man doxxed after exposing his city’s booming Islamic surge takes defiant stand: ‘Not gonna stop’

How Ms. Rachel went from beloved children’s streaming sensation to ‘mouthpiece for Hamas’

Nicki Minaj urges young Americans to ‘vote red’ in 2026 midterms while doubling down on Trump support

Florida man, 76, with suspended license allegedly admits to driving under the influence of rum, cocaine

Hiker falls up to 1,000 feet to his death day after another body found on same mountain

Four Americans dead after building collapses near the Acropolis in Athens

So-Called Moderate Governor Candidate Wants More Trans Books in Elementary Schools

Leading Democrat Official Resigns After Probe Uncovers Sexual Harassment of Young Female Staffer

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”